Effect of Renin-Angiotensin System on Platelet in Patient With Sepsis
ERASPPWS
Study on the Effect of Renin-Angiotensin System on Thrombocytopenia in Patient With Sepsis
1 other identifier
observational
53
1 country
1
Brief Summary
As a common and serious medical condition , sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection , which is a major and familiar cause of death in intensive care units(ICU). As a frequent laboratory abnormality in patients with sepsis , thrombocytopenia on intensive care unit admission is independently associated with increased mortality in patients. Furthermore, a low platelet count is a marker with further significance , which is always used for evaluating the prognosis of patients. Herein, this study aimed to investigate the effect of renin-angiotensin system on thrombocytopenia in patient with sepsis and explore the possible underlying molecular mechanisms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2018
CompletedFirst Submitted
Initial submission to the registry
January 15, 2019
CompletedFirst Posted
Study publicly available on registry
May 16, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 10, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2019
CompletedJanuary 18, 2020
December 1, 2018
1.9 years
January 15, 2019
January 14, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Platelet Count of Blood Sample
The platelet count of venous blood samples collected from patients with sepsis was measured by Blood routine instrument,Beckman CoulterLH750.
20-60min
The Plasma Renin Activity of Blood Sample
Venous blood samples were collected in ethylenediaminetetraacetic acid (EDTA),dimercaptopropanol and 8 - hydroxyquinoline sulfate plus blood collection tubes, followed by centrifugation to separate plasma from venous blood samples.The plasma renin activity of venous blood samples collected from patients with sepsis was measured by Iodine\[125I\]AngiotensinⅡRadioimmunoassay Kit.
20-60min
The Plasma Concentration of AngiotensinⅡ in Blood Sample
Venous blood samples were collected in ethylenediaminetetraacetic acid (EDTA) ,dimercaptopropanol and 8 - hydroxyquinoline sulfate plus blood collection tubes, followed by centrifugation to separate plasma from venous blood samples.The plasma concentration of angiotensinⅡ in venous blood samples collected from patients with sepsis was measured by Iodine\[125I\]AngiotensinⅡRadioimmunoassay Kit.
20-60min
Secondary Outcomes (2)
Correlation Coefficient (r) Between Platelet Count and The Plasma Renin Activity
20-60min
Correlation Coefficient (r) Between Platelet Count and The Plasma Concentration of AngiotensinⅡ
20-60min
Study Arms (2)
control
healthy volunteers
sepsis
patients with sepsis
Interventions
Eligibility Criteria
patients with sepsis
You may qualify if:
- Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection.
- Organ dysfunction can be identified as an acute change in total SOFA score ≥2 points consequent to the infection.
- The baseline SOFA score can be assumed to be zero in patients not known to have preexisting organ dysfunction.
- ASOFA score ≥2 reflects an overall mortality risk of approximately 10% in a general hospital population with suspected infection. Even patients presenting with modest dysfunction can deteriorate further,emphasizing the seriousness of this condition and the need for prompt and appropriate intervention, if not already being instituted.
- In lay terms, sepsis is a life-threatening condition that arises when the body's response to an infection injures its own tissues and organs.
- Patients with suspected infection who are likely to have a prolonged ICU stay or to die in the hospital can be promptly identified at the bedside with qSOFA, ie, alteration in mental status, systolic blood pressure ≥100 mm Hg, or respiratory rate ≥22/min.
- Septic shock is a subset of sepsis in which underlying circulatory and cellular/metabolic abnormalities are profound enough to substantially increase mortality.
- Patients with septic shock can be identified with a clinical construct of sepsis with persisting hypotension requiring vasopressors to maintain MAP ≥65 mm Hg and having a serum lactate level \>2 mmol/L (18mg/dL) despite adequate volume resuscitation. With these criteria,hospital mortality is in excess of 40%.
- Abbreviations: MAP, mean arterial pressure; qSOFA, quick SOFA; SOFA: Sequential\[Sepsis-related\] Organ Failure Assessment.
You may not qualify if:
- Pregnant or lactation period.
- Age \<18 years or \>85 years.
- Receiving chemotherapy, steroid or immunosuppressive agents recently.
- Receiving any drugs that affect Renin-Angiotensin-System(RAS),sunch as Angiotensin Converting Enzyme Inhibitor(ACEI),Angiotensin Receptor Blockers(ARB),diuretics,calcium channel blockers and other antihypertensives within two weeks .
- Receiving oral contraceptives within twelve weeks.
- Enrollment before resuscitation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Anesthesia, Shanghai Xinhua hospital
Shanghai, Shanghai Municipality, 200082, China
Biospecimen
plasma seperated from venous blood via centrifugation
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Lai Jiang, chief doctor
Xinhua Hospital affiliated to Medicine school,Shanghai Jiaotong University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 15, 2019
First Posted
May 16, 2019
Study Start
January 1, 2018
Primary Completion
December 10, 2019
Study Completion
December 15, 2019
Last Updated
January 18, 2020
Record last verified: 2018-12